BackAssertio Holdings Overview

Assertio Holdings Total Revenue

Track Assertio Holdings's total revenue ($100M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Revenue

$9.93M
62.5% YoY

As of Mar 2026

Annual Revenue (TTM)

$102.16M
14.15% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading

Assertio Holdings (ASRT) FAQ

The latest total revenue for ASRT is $100M as of March 2026. That compares with $120M in the prior-year period — down 14.2% year over year. That is below the Healthcare sector average of $110B. Investors often review this figure alongside Assertio Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, ASRT's total revenue moved from $120M to $100M — a 14.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Assertio Holdings's operating scale or balance-sheet position.

Against Healthcare companies, ASRT currently prints $100M for total revenue, while the sector average sits near $110B. That is roughly 99.9% below the sector mean. Large gaps often invite a closer look at Assertio Holdings's growth, margins, and balance sheet.

A total revenue figure of $100M for ASRT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $110B. Explore the charts below for those layers of context.

After noting ASRT's total revenue ($100M), review year-over-year change from $120M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.